Asthma and leukotrienes: antileukotrienes as novel anti‐asthmatic drugs
- 1 March 1999
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 245 (3) , 205-227
- https://doi.org/10.1046/j.1365-2796.1999.00418.x
Abstract
Antileukotriene drugs inhibit the formation or action of leukotrienes, which are potent lipid mediators generated from arachidonic acid in lung tissue and inflammatory cells. The leukotrienes were discovered in basic studies of arachidonic acid metabolism in leucocytes 20 years ago and were found to display a number of biological activities which may contribute to airway obstruction. Clinical studies with antileukotriene drugs have indeed demonstrated that leukotrienes are significant mediators of airway obstruction evoked by many common trigger factors in asthma. Moreover, treatment trials have established that this new class of drugs has beneficial anti-asthmatic properties, and several antileukotrienes have recently been introduced as new therapy of asthma. This communication presents an overview of the biosynthesis of leukotrienes, their biological effects and clinical effects of antileukotrienes in the treatment of asthama.Keywords
This publication has 101 references indexed in Scilit:
- The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient miceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Cloning of the guinea pig 5-lipoxygenase gene and nucleotide sequence of its promoterBiochemical and Biophysical Research Communications, 1992
- Human B lymphocytes possess 5-lipoxygenase activity and convert arachidonic acid to leukotriene B4Biochemical and Biophysical Research Communications, 1991
- Leukotriene A4 hydrolase is a zinc-containing aminopeptidaseBiochemical and Biophysical Research Communications, 1990
- Leukotriene A4 hydrolase: A zinc metalloenzymeBiochemical and Biophysical Research Communications, 1990
- Regulation of prostaglandin formation by glucocorticoids and their second messenger, lipocortinsJournal of Steroid Biochemistry, 1987
- Activation of leukocyte movement and displacement of [3H]leukotriene B4 from leukocyte membrane preparations by (12R)-and (12S)-hydroxyeicosatetraenoic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Airway Responsiveness to Leukotrienes C4 and D4 and to Methacholine in Patients with Asthma and Normal ControlsNew England Journal of Medicine, 1986
- Effects of Leukotriene D on the Airways in AsthmaNew England Journal of Medicine, 1983
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981